HIV-1 pre-mRNA commitment to Rev mediated export through PSF and Matrin 3

Virology

Volumn 435, Issue 2, 2013, Pages 329-340

  Kula, Anna ^a   Gharu, Lavina ^a   Marcello, Alessandro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Gene expression; HIV 1; Matrin 3; Nucleus; PSF; Rev; RNA binding protein; RNA processing

Indexed keywords

CELL PROTEIN; MESSENGER RNA PRECURSOR; NUCLEAR MATRIX PROTEIN; PROTEIN MATR3; PROTEIN PSF; REV PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; VIRUS TRANSCRIPTION;

ACTIVE TRANSPORT, CELL NUCLEUS; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMANS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, VIRAL; RNA-BINDING PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871676628     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.10.032     Document Type: Article

References (68)

1. Amendt B.A., Hesslein D., Chang L.J., Stoltzfus C.M. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell Biol. 1994, 14(6):3960-3970.
2. Amendt B.A., Si Z.H., Stoltzfus C.M. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell Biol. 1995, 15(8):4606-4615.
3. Belgrader P., Dey R., Berezney R. Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain. J. Biol. Chem. 1991, 266(15):9893-9899.
4. Berthold E., Maldarelli F. Cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. J. Virol. 1996, 70(7):4667-4682.
5. Boireau S., Maiuri P., Basyuk E., de la Mata M., Knezevich A., Pradet-Balade B., Backer V., Kornblihtt A., Marcello A., Bertrand E. The transcriptional cycle of HIV-1 in real-time and live cells. J. Cell Biol. 2007, 179(2):291-304.
6. Bourara K., Litvak S., Araya A. Generation of G-to-A and C-to-U changes in HIV-1 transcripts by RNA editing. Science 2000, 289(5484):1564-1566.
7. Caputi M., Mayeda A., Krainer A.R., Zahler A.M. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. Embo J. 1999, 18(14):4060-4067.
8. Chang D.D., Sharp P.A. Regulation by HIV Rev depends upon recognition of splice sites. Cell 1989, 59(5):789-795.
9. Cochrane A.W., Jones K.S., Beidas S., Dillon P.J., Skalka A.M., Rosen C.A. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 1991, 65(10):5305-5313.
10. Daugherty M.D., Liu B., Frankel A.D. Structural basis for cooperative RNA binding and export complex assembly by HIV Rev. Nat. Struct. Mol. Biol. 2010, 17(11):1337-1342.
11. De Marco A., Biancotto C., Knezevich A., Maiuri P., Vardabasso C., Marcello A. Intragenic transcriptional cis-activation of the human immunodeficiency virus 1 does not result in allele-specific inhibition of the endogenous gene. Retrovirology 2008, 5(1):98.
12. De Marco A., Dans P.D., Knezevich A., Maiuri P., Pantano S., Marcello A. Subcellular localization of the interaction between the human immunodeficiency virus transactivator Tat and the nucleosome assembly protein 1. Amino Acids 2010, 38(5):1583-1593.
13. Dieudonne M., Maiuri P., Biancotto C., Knezevich A., Kula A., Lusic M., Marcello A. Transcriptional competence of the integrated HIV-1 provirus at the nuclear periphery. Embo J. 2009, 28(15):2231-2243.
14. Dyhr-Mikkelsen H., Kjems J. Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro. J. Biol. Chem. 1995, 270(41):24060-24066.
15. Emili A., Shales M., McCracken S., Xie W., Tucker P.W., Kobayashi R., Blencowe B.J., Ingles C.J. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD. RNA 2002, 8(9):1102-1111.
16. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997, 90(6):1051-1060.
17. Greco-Stewart V.S., Thibault C.S., Pelchat M. Binding of the polypyrimidine tract-binding protein-associated splicing factor (PSF) to the hepatitis delta virus RNA. Virology 2006, 356(1-2):35-44.
18. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy. Nat. Med. 2002, 8(7):673-680.
19. He D.C., Nickerson J.A., Penman S. Core filaments of the nuclear matrix. J. Cell Biol. 1990, 110(3):569-580.
20. Hibino Y., Usui T., Morita Y., Hirose N., Okazaki M., Sugano N., Hiraga K. Molecular properties and intracellular localization of rat liver nuclear scaffold protein P130. Biochim. Biophys. Acta 2006, 1759(5):195-207.
21. Iacampo S., Cochrane A. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J. Virol. 1996, 70(12):8332-8339.
22. Kaneko S., Rozenblatt-Rosen O., Meyerson M., Manley J.L. The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination. Genes Dev. 2007, 21(14):1779-1789.
23. Kjems J., Brown M., Chang D.D., Sharp P.A. Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc. Natl. Acad. Sci. U S A 1991, 88(3):683-687.
24. Kula A., Guerra J., Knezevich A., Kleva D., Myers M.P., Marcello A. Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function. Retrovirology 2011, 8(1):60.
25. Kula A., Marcello A. Dynamic post-transcriptional regulation of HIV-1 gene expression. Biology 2012, 1:116-133.
26. Landeras-Bueno S., Jorba N., Perez-Cidoncha M., Ortin J. The splicing factor proline-glutamine rich (SFPQ/PSF) is involved in influenza virus transcription. PLoS Pathog. 2011, 7(11):e1002397.
27. Luo Y., Madore S.J., Parslow T.G., Cullen B.R., Peterlin B.M. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J. Virol. 1993, 67(9):5617-5622.
28. Maiuri P., Knezevich A., Bertrand E., Marcello A. Real-time imaging of the HIV-1 transcription cycle in single living cells. Methods 2011, 53(1):62-67.
29. Maiuri P., Knezevich A., De Marco A., Mazza D., Kula A., McNally J.G., Marcello A. Fast transcription rates of RNA polymerase II in human cells. EMBO Rep. 2011, 12(12):1280-1285.
30. Maldarelli F., Martin M.A., Strebel K. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 1991, 65(11):5732-5743.
31. Malim M.H., Cullen B.R. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 1991, 65(2):241-248.
32. Malim M.H., Hauber J., Le S.Y., Maizel J.V., Cullen B.R. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989, 338(6212):254-257.
33. Malyavantham K.S., Bhattacharya S., Barbeitos M., Mukherjee L., Xu J., Fackelmayer F.O., Berezney R. Identifying functional neighborhoods within the cell nucleus: proximity analysis of early S-phase replicating chromatin domains to sites of transcription, RNA polymerase II, HP1gamma, matrin 3 and SAF-A. J. Cell. Biochem. 2008, 105(2):391-403.
34. Marcello A., Cinelli R.A., Ferrari A., Signorelli A., Tyagi M., Pellegrini V., Beltram F., Giacca M. Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer. J. Biol. Chem. 2001, 276(42):39220-39225.
35. Marcello A., Dhir S., Dieudonne M. Nuclear positional control of HIV transcription in 4D. Nucleus 2010, 1(1):8-11.
36. Marcello A., Ferrari A., Pellegrini V., Pegoraro G., Lusic M., Beltram F., Giacca M. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. Embo J. 2003, 22(9):2156-2166.
37. Marcello A., Giaretta I. Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector. Res. Virol. 1998, 149(6):419-431.
38. Mikaelian I., Krieg M., Gait M.J., Karn J. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs. J. Mol. Biol. 1996, 257(2):246-264.
39. Miorin L., Maiuri P., Hoenninger V.M., Mandl C.W., Marcello A. Spatial and temporal organization of tick-borne encephalitis flavivirus replicated RNA in living cells. Virology 2008, 379(1):64-77.
40. Molle D., Maiuri P., Boireau S., Bertrand E., Knezevich A., Marcello A., Basyuk E. A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites. Retrovirology 2007, 4:36.
41. Mortillaro M.J., Blencowe B.J., Wei X., Nakayasu H., Du L., Warren S.L., Sharp P.A., Berezney R. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. USA 1996, 93(16):8253-8257.
42. Najera I., Krieg M., Karn J. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1. J. Mol. Biol. 1999, 285(5):1951-1964.
43. Naji S., Ambrus G., Cimermancic P., Reyes J.R., Johnson J.R., Filbrandt R., Huber M.D., Vesely P., Krogan N.J., Yates J.R., Saphire A.C., Gerace L. Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol. Cell Proteomics 2011.
44. Nakayasu H., Berezney R. Nuclear matrins: identification of the major nuclear matrix proteins. Proc. Natl. Acad. Sci. USA 1991, 88(22):10312-10316.
45. Nasioulas G., Zolotukhin A.S., Tabernero C., Solomin L., Cunningham C.P., Pavlakis G.N., Felber B.K. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 1994, 68(5):2986-2993.
46. O'Reilly M.M., McNally M.T., Beemon K.L. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 1995, 213(2):373-385.
47. Phuphuakrat A., Kraiwong R., Boonarkart C., Lauhakirti D., Lee T.H., Auewarakul P. Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J. Virol. 2008, 82(21):10864-10872.
48. Pollard V.W., Malim M.H. The HIV-1 Rev protein. Annu. Rev. Microbiol. 1998, 52:491-532.
49. Prasanth K.V., Prasanth S.G., Xuan Z., Hearn S., Freier S.M., Bennett C.F., Zhang M.Q., Spector D.L. Regulating gene expression through RNA nuclear retention. Cell 2005, 123(2):249-263.
50. Purcell D.F., Martin M.A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 1993, 67(11):6365-6378.
51. Sasaki Y.T., Ideue T., Sano M., Mituyama T., Hirose T. MEN{varepsilon}/{beta} noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proc. Natl. Acad. Sci. USA 2009.
52. Schneider R., Campbell M., Nasioulas G., Felber B.K., Pavlakis G.N. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 1997, 71(7):4892-4903.
53. Schwartz S., Campbell M., Nasioulas G., Harrison J., Felber B.K., Pavlakis G.N. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 1992, 66(12):7176-7182.
54. Schwartz S., Felber B.K., Benko D.M., Fenyo E.M., Pavlakis G.N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 1990, 64(6):2519-2529.
55. Sharmeen L., Bass B., Sonenberg N., Weintraub H., Groudine M. Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc. Natl. Acad. Sci. USA 1991, 88(18):8096-8100.
56. Shav-Tal Y., Zipori D. PSF and p54(nrb)/NonO-multi-functional nuclear proteins. FEBS Lett. 2002, 531(2):109-114.
57. Si Z., Amendt B.A., Stoltzfus C.M. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res. 1997, 25(4):861-867.
58. Sodroski J., Goh W.C., Rosen C., Dayton A., Terwilliger E., Haseltine W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 1986, 321(6068):412-417.
59. Southgate C., Zapp M.L., Green M.R. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature 1990, 345(6276):640-642.
60. Staffa A., Cochrane A. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site. J. Virol. 1994, 68(5):3071-3079.
61. Staffa A., Cochrane A. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell Biol. 1995, 15(8):4597-4605.
62. Tange T.O., Damgaard C.K., Guth S., Valcarcel J., Kjems J. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. Embo. J. 2001, 20(20):5748-5758.
63. Yedavalli V.S., Jeang K.T. Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology 2011, 8:61.
64. Yedavalli V.S., Jeang K.T. Rev-ing up post-transcriptional HIV-1 RNA expression. RNA Biol. 2011, 8(2):195-199.
65. Zapp M.L., Green M.R. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 1989, 342(6250):714-716.
66. Zeitz M.J., Malyavantham K.S., Seifert B., Berezney R. Matrin 3: chromosomal distribution and protein interactions. J. Cell Biochem. 2009, 108(1):125-133.
67. Zhang Z., Carmichael G.G. The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 2001, 106(4):465-475.
68. Zolotukhin A.S., Michalowski D., Bear J., Smulevitch S.V., Traish A.M., Peng R., Patton J., Shatsky I.N., Felber B.K. PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol. Cell. Biol. 2003, 23(18):6618-6630.